Patents by Inventor Sarah Donald

Sarah Donald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
    Publication number: 20240182455
    Abstract: Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.
    Type: Application
    Filed: October 20, 2023
    Publication date: June 6, 2024
    Inventors: Elizabeth Mary Beck, Steven John Durrant, Sarah Skerratt, Robert Pullin, Gorka Etxebarria Jardi, David Matthew Shaw, Nadia M. Ahmad, Christopher Wray, Anisa Nizarali Virani, Kiri North, James Dodd, Michael Edward O'Donnell, Bhairavi Galan, Ronald Marcellus Knegtel, Ewa Iwona Chudyk, Joanne Louise Pinder, Stephen Andrew Thomson, Lidio Marx Carvalho Meireles, Dean Stamos, Yvonne Schmidt, Joseph Pontillo, Sara S. Hadida Ruah, Timothy Donald Neubert, Dennis James Hurley, Jinglan Zhou
  • Novel Synthetic Polymers and Crosslinked Hydrogel Systems
    Publication number: 20240150509
    Abstract: A novel synthetic functionalized backbone polymer is provided which is a polyanionic side-chain functionalized backbone polymer comprising a hydrophilic backbone polymer functionalized with an activated alkene or epoxy group. The functionalized backbone polymer may be combined with a free or protected thiol-containing compound to form a crosslinked hydrogel having biomedical application, and may additionally be combined with a hydrogel matrix to yield a hydrogel system useful for in vivo delivery of cells and other therapeutic agents.
    Type: Application
    Filed: January 9, 2024
    Publication date: May 9, 2024
    Inventors: Sarah Alison Stewart, Harald Donald Helmut Stover, Michael Bradley Coulson
  • INTELLIGENT WORKFLOW FOR HEALTHCARE
    Publication number: 20240144381
    Abstract: Device data is obtained from one or more devices for an individual. The one or more devices include one or more medical monitoring devices. Data is also obtained from one or more exogenous sources, and the data includes current data relating to one or more medical resources. The device data obtained from the one or more devices and the data from the one or more exogenous sources are analyzed using an artificial intelligence agent. Based on the analyzing, one or more recommendations are provided. The one or more recommendations include an indication of a device to use that is different from the one or more devices to obtain different device data for the individual.
    Type: Application
    Filed: November 2, 2022
    Publication date: May 2, 2024
    Inventors: Michael Jack MARTINE, Sarah Diane GREEN, David DRAEGER, Stan Kevin DALEY, Ira L. ALLEN, John Donald VASQUEZ
  • Substituted tetrahydrofurans as modulators of sodium channels
    Patent number: 11919887
    Abstract: Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: March 5, 2024
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Steven John Durrant, Nadia M. Ahmad, Elizabeth Mary Beck, Lidio Marx Carvalho Meireles, Ewa Iwona Chudyk, Gorka Etxebarria Jardi, Bhairavi Galan, Sara S. Hadida Ruah, Dennis James Hurley, Ronald Marcellus Knegtel, Timothy Donald Neubert, Joanne Louise Pinder, Joseph Pontillo, Robert Pullin, Yvonne Schmidt, David Matthew Shaw, Sarah Skerratt, Dean Stamos, Stephen Andrew Thomson, Anisa Nizarali Virani, Christopher Wray
  • Antitumoral combinations containing et-743 and a cruciferous and a cruciferous indole compound
    Publication number: 20070004691
    Abstract: Administration of a cruciferous indole compound can reduce undesirable toxic side effects inherent in the anti-tumor therapy with ET-743 before during or after administration of the ET-743.
    Type: Application
    Filed: October 14, 2004
    Publication date: January 4, 2007
    Inventors: Sarah Donald, Andreas Gescher, Jose Donaque